Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021673
Filing Date
2020-02-14
Accepted
2020-02-14 16:05:05
Documents
1
Group Members
BRIAN D. GROSSMANCHRISTOPHER M. JAMESPARTNER FUND MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT GP, LLCPARTNER INVESTMENT MANAGEMENT, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207213d11_sc13ga.htm SC 13G/A 184982
  Complete submission text file 0001104659-20-021673.txt   186779
Mailing Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111
Business Address FOUR EMBARCADERO CENTER SUITE 3500 SAN FRANCISCO CA 94111 415-281-1022
Partner Fund Management, L.P. (Filed by) CIK: 0001442756 (see all company filings)

EIN.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88577 | Film No.: 20619388
SIC: 2836 Biological Products, (No Diagnostic Substances)